• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管原位癌:护理及生存的地理、时间和人口统计学模式趋势

Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.

作者信息

Joslyn Sue A

机构信息

University of Northern Iowa, Cedar Falls, Iowa 50614-0135, USA.

出版信息

Breast J. 2006 Jan-Feb;12(1):20-7. doi: 10.1111/j.1075-122X.2006.00182.x.

DOI:10.1111/j.1075-122X.2006.00182.x
PMID:16409583
Abstract

While long-term prognosis is excellent, treatment of ductal carcinoma in situ (DCIS) remains controversial and inconsistent. The purpose of this study was to track geographic and temporal patterns of care for women diagnosed with DCIS, and analyze subsequent cancer-specific risk of mortality. Subjects for this study were 41,245 women diagnosed with primary DCIS in the National Surveillance, Epidemiology, and End Results (SEER) program from 1973 through 2000. Variables analyzed included patient age, year of diagnosis, SEER site of residence at the time of diagnosis, treatment (surgery, radiation), race, age, and hormone (estrogen and progesterone) receptor status. The percentage of women diagnosed with DCIS out of the total number of women diagnosed with breast cancer increased steadily between 1973 and 2000, with the largest increase occurring around 1985. Breast conserving surgery (BCS) utilization increased over time for each SEER site to the current proportions, ranging from 49.5% in Utah to 76.9% in Connecticut. Younger women were significantly more likely to receive mastectomy and had significantly lower risk of death. Women receiving BCS who also had radiation therapy (RT) had a significantly lower risk of death, although those receiving mastectomy had the lowest risk of death. Black women and Asian/Pacific island women were significantly more likely to receive BCS, although black women were less likely to receive follow-up RT and had a significantly increased risk of death. Racial and age differences in the treatment of DCIS resulted in significantly disparate rates of survival, which should be considered in public health programming. Mastectomy utilization resulted in improved survival, although additional studies may elucidate the interaction of treatment with patient age.

摘要

虽然导管原位癌(DCIS)的长期预后良好,但其治疗仍存在争议且不一致。本研究的目的是追踪被诊断为DCIS的女性的治疗地域和时间模式,并分析随后特定癌症的死亡风险。本研究的对象是1973年至2000年在国家监测、流行病学和最终结果(SEER)计划中被诊断为原发性DCIS的41,245名女性。分析的变量包括患者年龄、诊断年份、诊断时SEER居住地点、治疗(手术、放疗)、种族、年龄以及激素(雌激素和孕激素)受体状态。1973年至2000年期间,被诊断为DCIS的女性在所有被诊断为乳腺癌的女性总数中所占的百分比稳步上升,最大增幅出现在1985年左右。随着时间的推移,每个SEER地区保乳手术(BCS)的使用率都增加到了目前的比例,从犹他州的49.5%到康涅狄格州的76.9%不等。年轻女性接受乳房切除术的可能性显著更高,且死亡风险显著更低。接受BCS且同时接受放疗(RT)的女性死亡风险显著更低,尽管接受乳房切除术的女性死亡风险最低。黑人女性和亚裔/太平洋岛民女性接受BCS的可能性显著更高,尽管黑人女性接受后续RT的可能性较小且死亡风险显著增加。DCIS治疗中的种族和年龄差异导致了显著不同的生存率,这在公共卫生规划中应予以考虑。乳房切除术的使用提高了生存率,尽管更多研究可能会阐明治疗与患者年龄之间的相互作用。

相似文献

1
Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.导管原位癌:护理及生存的地理、时间和人口统计学模式趋势
Breast J. 2006 Jan-Feb;12(1):20-7. doi: 10.1111/j.1075-122X.2006.00182.x.
2
Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999.1988 - 1999年路易斯安那州乳腺导管原位癌的治疗模式
J La State Med Soc. 2003 Jul-Aug;155(4):206-13.
3
The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.DCIS保乳手术后同侧第二原发肿瘤的发生率:一项基于人群的分析。
Cancer. 2005 Nov 1;104(9):1840-8. doi: 10.1002/cncr.21406.
4
Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.荷兰东部基于人群的研究:不同治疗策略治疗乳腺导管原位癌后的局部复发情况
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):703-10. doi: 10.1016/j.ijrobp.2007.03.062. Epub 2007 Jun 4.
5
Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer.导管原位癌或早期浸润性乳腺癌女性患者放疗不足的相关因素及影响
Cancer. 2008 Dec 1;113(11):3108-15. doi: 10.1002/cncr.23923.
6
Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.1988 - 2001年原位导管癌和原位小叶癌女性患者发生浸润性乳腺癌的风险
Cancer. 2006 May 15;106(10):2104-12. doi: 10.1002/cncr.21864.
7
The management of ductal carcinoma in situ of the breast: a screened population-based analysis.乳腺导管原位癌的管理:一项基于筛查人群的分析。
Breast Cancer Res Treat. 2007 Mar;101(3):335-47. doi: 10.1007/s10549-006-9302-0. Epub 2006 Jul 13.
8
Regional differences in the incidence and treatment of carcinoma in situ of the breast.乳腺原位癌发病率及治疗的地区差异
Cancer Epidemiol Biomarkers Prev. 1996 Apr;5(4):317-20.
9
Effectiveness of radiation therapy in older women with ductal carcinoma in situ.放射治疗对老年导管原位癌女性患者的疗效
J Natl Cancer Inst. 2006 Sep 20;98(18):1302-10. doi: 10.1093/jnci/djj359.
10
Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program.女性乳腺恶性叶状肿瘤:来自监测、流行病学和最终结果(SEER)项目的初始治疗与特定病因生存率的关联
Cancer. 2006 Nov 1;107(9):2127-33. doi: 10.1002/cncr.22228.

引用本文的文献

1
Ductal Carcinoma In Situ of the Breast: Perspectives on Tumor Subtype and Treatment.乳腺导管原位癌:肿瘤亚型和治疗的观点。
Biomed Res Int. 2020 May 27;2020:7251431. doi: 10.1155/2020/7251431. eCollection 2020.
2
Treatment and Survival Disparities in the National Cancer Institute's Patterns of Care Study (1987-2017).美国国立癌症研究所照护模式研究(1987 - 2017年)中的治疗与生存差异
Cancer Invest. 2018;36(6):319-329. doi: 10.1080/07357907.2018.1474894. Epub 2018 Aug 23.
3
Prophylactic mastectomy for the prevention of breast cancer: Review of the literature.
预防性乳房切除术预防乳腺癌:文献综述
Avicenna J Med. 2018 Jul-Sep;8(3):67-77. doi: 10.4103/ajm.AJM_21_18.
4
Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer.硅橡胶管局部递药用于预防和治疗乳腺癌的激素治疗。
Sci Rep. 2018 Jan 8;8(1):92. doi: 10.1038/s41598-017-18436-1.
5
Breast carcinoma in situ: An observational study of tumor subtype, treatment and outcomes.乳腺原位癌:肿瘤亚型、治疗及预后的观察性研究
Oncotarget. 2017 Jan 10;8(2):2361-2371. doi: 10.18632/oncotarget.13785.
6
Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ.原位导管癌女性患者手术及辅助放疗的新趋势
Cancer. 2016 Sep 15;122(18):2810-8. doi: 10.1002/cncr.30105. Epub 2016 May 31.
7
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.一项基于人群的验证性研究,评估DCIS评分对仅接受保乳手术治疗的个体复发风险的预测作用。
Breast Cancer Res Treat. 2015 Jul;152(2):389-98. doi: 10.1007/s10549-015-3464-6. Epub 2015 Jun 29.
8
Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast.乳腺导管原位癌女性中乳腺癌、心血管疾病及全因死亡率的种族差异。
Breast Cancer Res Treat. 2014 Nov;148(2):407-13. doi: 10.1007/s10549-014-3168-3. Epub 2014 Oct 18.
9
Ductal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients.乳腺导管原位癌:评估放射治疗在管理中的作用及识别低风险患者的尝试
Am J Clin Oncol. 2015 Oct;38(5):526-33. doi: 10.1097/COC.0000000000000102.
10
Ductal carcinoma in situ of the breast: a surgical perspective.乳腺导管原位癌:外科视角
Int J Surg Oncol. 2012;2012:761364. doi: 10.1155/2012/761364. Epub 2012 Sep 4.